广西医学
廣西醫學
엄서의학
Guangxi Medical Journal
2015年
8期
1131-1133
,共3页
李树铁%汪业铭%李媛莉%陈琛%王磊%姜伟%李福龙
李樹鐵%汪業銘%李媛莉%陳琛%王磊%薑偉%李福龍
리수철%왕업명%리원리%진침%왕뢰%강위%리복룡
慢性阻塞性肺疾病%急性加重期%有创机械通气%丹参多酚酸盐%肺部感染
慢性阻塞性肺疾病%急性加重期%有創機械通氣%丹參多酚痠鹽%肺部感染
만성조새성폐질병%급성가중기%유창궤계통기%단삼다분산염%폐부감염
Chronic obstructive pulmonary disease%Acute exacerbation%Invasive mechanical ventilation%Salvianolate%Pulmonary infection
目的 探讨丹参多酚酸盐对有创机械通气的急性加重期慢性阻塞性肺疾病( AECOPD)患者肺部感染发生率的影响. 方法 行有创机械通气治疗的AECOPD患者40例,依据数字分组法随机分为两组,各20例. 对照组给予有创机械通气和常规西药治疗,观察组在对照组基础上加用丹参多酚酸盐静脉滴注. 对比两组呼吸机相关性肺部感染( VAP)发生率,以及治疗前后动脉血液酸碱度( pH)、氧分压( PaO2 )、二氧化碳分压( PaCO2 )、血氧饱和度( SaO2 )、机械通气时间及临床肺部感染评分(CPIS)变化. 结果 治疗前两组pH、PaO2、PaCO2、SaO2 及CPIS比较,差异无统计学意义(P均>0.05);治疗后观察组pH、PaO2、PaCO2、SaO2 及CPIS和对照组较治疗前均明显改善(P<0.05),且观察组各指标改善明显优于对照组(P<0.05). 观察组机械通气时间为(9.38 ±4.27)d,明显短于对照组的(13.91 ±7.78)d(P <0.05);观察组 VAP 发生率15.0%(3/20),明显低于对照组的45.0%(9/20)(P<0.05). 结论 丹参多酚酸盐可改善有创机械通气的AECOPD患者动脉血气指标,降低VAP发生率,缩短有创机械通气时间,改善临床预后.
目的 探討丹參多酚痠鹽對有創機械通氣的急性加重期慢性阻塞性肺疾病( AECOPD)患者肺部感染髮生率的影響. 方法 行有創機械通氣治療的AECOPD患者40例,依據數字分組法隨機分為兩組,各20例. 對照組給予有創機械通氣和常規西藥治療,觀察組在對照組基礎上加用丹參多酚痠鹽靜脈滴註. 對比兩組呼吸機相關性肺部感染( VAP)髮生率,以及治療前後動脈血液痠堿度( pH)、氧分壓( PaO2 )、二氧化碳分壓( PaCO2 )、血氧飽和度( SaO2 )、機械通氣時間及臨床肺部感染評分(CPIS)變化. 結果 治療前兩組pH、PaO2、PaCO2、SaO2 及CPIS比較,差異無統計學意義(P均>0.05);治療後觀察組pH、PaO2、PaCO2、SaO2 及CPIS和對照組較治療前均明顯改善(P<0.05),且觀察組各指標改善明顯優于對照組(P<0.05). 觀察組機械通氣時間為(9.38 ±4.27)d,明顯短于對照組的(13.91 ±7.78)d(P <0.05);觀察組 VAP 髮生率15.0%(3/20),明顯低于對照組的45.0%(9/20)(P<0.05). 結論 丹參多酚痠鹽可改善有創機械通氣的AECOPD患者動脈血氣指標,降低VAP髮生率,縮短有創機械通氣時間,改善臨床預後.
목적 탐토단삼다분산염대유창궤계통기적급성가중기만성조새성폐질병( AECOPD)환자폐부감염발생솔적영향. 방법 행유창궤계통기치료적AECOPD환자40례,의거수자분조법수궤분위량조,각20례. 대조조급여유창궤계통기화상규서약치료,관찰조재대조조기출상가용단삼다분산염정맥적주. 대비량조호흡궤상관성폐부감염( VAP)발생솔,이급치료전후동맥혈액산감도( pH)、양분압( PaO2 )、이양화탄분압( PaCO2 )、혈양포화도( SaO2 )、궤계통기시간급림상폐부감염평분(CPIS)변화. 결과 치료전량조pH、PaO2、PaCO2、SaO2 급CPIS비교,차이무통계학의의(P균>0.05);치료후관찰조pH、PaO2、PaCO2、SaO2 급CPIS화대조조교치료전균명현개선(P<0.05),차관찰조각지표개선명현우우대조조(P<0.05). 관찰조궤계통기시간위(9.38 ±4.27)d,명현단우대조조적(13.91 ±7.78)d(P <0.05);관찰조 VAP 발생솔15.0%(3/20),명현저우대조조적45.0%(9/20)(P<0.05). 결론 단삼다분산염가개선유창궤계통기적AECOPD환자동맥혈기지표,강저VAP발생솔,축단유창궤계통기시간,개선림상예후.
Objective To explore the effect of salvianolate on the incidence of pulmonary infection in patients with acute exacerbation of chronic obstructive pulmonary disease ( AECOPD ) undergoing invasive mechanical ventilation.Methods Forty patients with AECOPD undergoing invasive mechanical ventilation were divided into two groups by random number table.Twenty cases in the control group were treated with invasive mechanical ventilation and conventional western medicine treatment,while 20 cases in the observation group received intravenous infusion of salvianolate(200 mg/time,once daily) besides the therapies applied to control group.The incidences of ventilator-associated pneumonia (VAP) were compared between two groups.Before and after the treatment,pH value of arterial blood,partial pressure of oxygen(PaO2), partial pressure of carbon dioxide( PaCO2 ) and oxygen saturation( SaO2 ) of arterial blood,duration of mechanical ventilation treatment and clinical pulmonary infection score( CPIS) were also compared between two groups.Results There were no significant differences in pH, PaO2,PaCO2,SaO2 or CPIS between two groups before treatment(all P>0.05).pH,PaO2,PaCO2,SaO2 and CPIS of observation group and pH,PaO2,SaO2 and CPIS of control groups improved significantly after treatment(P<0.05),and the improvement of each index of observation group was superior to that of control group(P<0.05).The duration of mechanical ventilation treatment in the observation group was significantly less than that in the control group((9.38 ±4.27)days vs.(13.91 ±7.78)days,P<0.05).The incidence of VAP in the observation group was significantly lower than that in the control group(15.0%(3/20) vs.45.0%(9/20),P<0.05).Conclusion For the patients with AECOPD undergoing invasive mechanical ventilation,the application of salvianolate can improve arterial blood gas index, reduce the incidence of VAP and the duration of mechanical ventilation treatment,and improve the clinical prognosis.